Clinical and molecular predictors of recurrence in stage i non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 93, Issue 5, 2012, Pages 1606-1612

  Starnes, Sandra L ^a,b,c   Pathrose, Peterson ^a,b,c   Wang, Jiang ^a,b,c   Succop, Paul ^a,b,c   Morris, John C ^a,b,c   Bridges, James ^a,b,c   Kupert, Elena Y ^a,b,c   Anderson, Marshall ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Department of Pathology and Environmental Health ^*  (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; VASCULOTROPIN;

ADJUVANT THERAPY; ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SURGICAL MORTALITY; TUMOR VOLUME;

EID: 84860237020     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.01.048     Document Type: Article

References (26)

1. A. Jemal, R. Siegel, J. Xu Cancer statistics 2010 CA Cancer J Clin 60 2010 277 300
2. T. Winton, R. Livingston, D. Johnson Vinorelbine plus cisplatin versus observation in resected non-small cell lung cancer N Engl J Med 352 2005 2589 2597 (Pubitemid 41007845)
3. The International Adjuvant Lung Cancer Trial Collaborative Group Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer New Engl J Med 350 2004 351 360
4. G.M. Strauss, J.E. Herndon, M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Oncology Group, and North Central Cancer Treatment Study Groups J Clin Oncol 26 2008 5043 5051
5. J.Y. Douillard, R. Rosell, M. De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomized controlled trial Lancet Oncol 7 2006 719 727 (Pubitemid 44283661)
6. J.P. Pignon, H. Tribodet, G.V. Scagliotti Lung Adjuvant Cisplatin Evaluation: a polled analysis by the LACE collaborative group J Clin Oncol 26 2008 3552 3559
7. F.C. Detterbeck, D.J. Boffa, L.T. Tanoue The new lung cancer staging system Chest 136 2009 260 271
8. J. Subramanian, R. Simon Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102 2010 464 474
9. R. Batevik, K. Grong, L. Segadal The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years Lung Cancer 47 2005 173 181 (Pubitemid 40082160)
10. H.A. Wakelee, W. Wang, J.H. Schiller Survival differences by sex for patients with advanced non-small cell lung cancer in Eastern Cooperative Oncology Group Trial 1594 J Thorac Oncol 1 2006 441 446 (Pubitemid 47181421)
11. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 203;9:669-76.
12. H. Han, J.F. Silverman, T.S. Santucci Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis Ann Surg Oncol 8 2001 72 79 (Pubitemid 32126827)
13. T.C. Mineo, V. Ambrogi, A. Baldi Prognostic impact of VEGF, CD31, CD34, and CD 105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J Clin Pathol 57 2004 591 597 (Pubitemid 38725758)
14. Y. Ohta, Y. Tomita, M. Oda Tumor angiogenesis and recurrence in stage I non-small cell lung cancer Ann Thorac Surg 68 1999 1034 1038 (Pubitemid 29526880)
15. M. Decaussin, H. Sartelet, C. Robert Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival J Pathol 188 1999 369 377 (Pubitemid 29327434)
16. T. Seto, M. Higashiyama, H. Funai Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small cell lung cancer Lung Cancer 53 2006 91 96 (Pubitemid 43831360)
17. S. Singhal, A. Vachani, D. Antin-Ozerkis, L. Kaiser, S. Albelda Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review Clin Cancer Res 11 2005 3974 3986 (Pubitemid 40791561)
18. C.-Q. Zhu, W. Shih, C.-H. Ling, M.-S. Tsao Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation J Clin Pathol 59 2006 790 800 (Pubitemid 44211740)
19. O. Gautschi, D. Ratschiller, M. Gugger Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation Lung Cancer 55 2007 1 14 (Pubitemid 46038884)
20. M. Jin, S. Inoue, T. Umemura Cyclin D1, p16, and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II Lung Cancer 34 2001 207 218 (Pubitemid 33010796)
21. M. Nishio, T. Koshikawa, Y. Yatabe Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers Clin Cancer Res 3 1997 1051 1058 (Pubitemid 27319750)
22. M. Gugger, A. Kappeler, S. Vonlanthen Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours Lung Cancer 33 2001 229 239 (Pubitemid 32707904)
23. E. Han, A. Sgambat, W. Jiang Stable expression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth Oncogene 10 1995 953 961
24. M. Pagano, A.M. Theodoras, S.W. Tam Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts Genes Dev 8 1994 1627 1639 (Pubitemid 24236242)
25. S. Paik, S. Shak, G. Tang A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826 (Pubitemid 40051905)
26. S. Paik, G. Tang, S. Shak Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 2006 3726 3734 (Pubitemid 46622311)